Treatment patterns for AL amyloidosis after frontline daratumumab, bortezomib, cyclophosphamide, and dexamethasone treatment failures
Leukemia
.
2024 Apr 9.
doi: 10.1038/s41375-024-02243-5.
Online ahead of print.
Authors
Saurabh Zanwar
1
,
Morie A Gertz
1
,
Eli Muchtar
1
,
Francis K Buadi
1
,
Taxiarchis Kourelis
1
,
Wilson Gonsalves
1
,
Ronald S Go
1
,
Suzanne Hayman
1
,
Prashant Kapoor
1
,
Moritz Binder
1
,
Joselle Cook
1
,
David Dingli
1
,
Nelson Leung
1
,
Yi Lin
1
,
Rahma Warsame
1
,
Amie Fonder
1
,
Miriam Hobbs
1
,
Yi Lisa Hwa
1
,
Robert A Kyle
1
,
S Vincent Rajkumar
1
,
Shaji Kumar
1
,
Angela Dispenzieri
2
Affiliations
1
Division of Hematology, Mayo Clinic, Rochester, MN, US.
2
Division of Hematology, Mayo Clinic, Rochester, MN, US. dispenzieri.angela@mayo.edu.
PMID:
38594348
DOI:
10.1038/s41375-024-02243-5
No abstract available